Apigenin is a plant compound that acts on several systems in your body at once: it calms brain activity through the same receptor that anti-anxiety drugs target, raises levels of a key molecule involved in cellular energy and aging, reduces a specific type of inflammation, and supports nerve cell growth. Found most abundantly in parsley, chamomile, and celery, it has become one of the more widely studied flavonoids in nutritional science. Here’s what it actually does and how much of it matters.
How Apigenin Affects the Brain
Apigenin binds to the same site on brain receptors that benzodiazepines (drugs like Valium and Xanax) use. These receptors, called GABA-A receptors, control how excitable your neurons are. When apigenin locks onto them, it produces a measurable anxiolytic (anxiety-reducing) effect. The key difference from pharmaceutical sedatives is what it doesn’t do: in animal studies, apigenin at doses comparable to standard benzodiazepines reduced anxiety without causing sedation, muscle relaxation, or anticonvulsant effects. It’s a lighter touch on the same system.
The interaction is more nuanced than a simple on-off switch. Some of apigenin’s effects on GABA receptors can be blocked by the same antidote used for benzodiazepine overdoses (flumazenil), while other effects cannot. This suggests apigenin works through multiple channels on the receptor, and possibly through other receptor types entirely.
Beyond calming neural activity, apigenin directly supports nerve cell growth. It physically binds to BDNF, a protein your brain uses to build and maintain neurons. When apigenin and BDNF are present together, the combination amplifies BDNF’s normal effects: hippocampal neurons treated with both compounds grew roughly eight dendrites per cell (the branching arms that receive signals from other neurons), and the number of synaptic connection points increased significantly. Apigenin enhances BDNF’s ability to activate its receptor, triggering a cascade that promotes neuronal differentiation and synapse formation. This synergy was confirmed by blocking the receptor with an inhibitor, which eliminated the effect entirely.
Raising NAD+ by Blocking CD38
One of apigenin’s most discussed effects involves a molecule called NAD+, which your cells use for energy production, DNA repair, and activating longevity-related enzymes. NAD+ levels decline with age, and a major reason is an enzyme called CD38 that breaks NAD+ down. Apigenin inhibits CD38.
In laboratory studies published in the journal Diabetes, apigenin blocked CD38’s NAD+-degrading activity at relatively low concentrations, and this inhibition worked both in isolated enzyme tests and inside living cells. The result was a dose-dependent increase in intracellular NAD+ levels. When researchers tested this in mice, animals injected with apigenin showed reduced CD38 activity in the liver and correspondingly higher hepatic NAD+ levels. The mechanism was confirmed using genetically modified mice that lacked CD38 altogether: apigenin had no effect on their NAD+ levels, proving that its NAD+-boosting action works specifically through CD38 inhibition rather than some other pathway.
Anti-Inflammatory Effects
Apigenin targets a specific inflammatory pathway called the NLRP3 inflammasome, a protein complex inside immune cells that triggers the release of a potent inflammatory signal called IL-1β. In both monocytes and macrophages (two types of immune cells), apigenin significantly inhibited IL-1β release in a dose-dependent manner when the cells were stimulated by multiple different triggers. Notably, it did not affect TNF release, a different inflammatory signal controlled by a separate pathway. This selectivity matters because it means apigenin isn’t broadly suppressing immune function; it’s targeting one specific arm of the inflammatory response.
The mechanism involves blocking calcium flow from internal cell storage into the main cell compartment, which disrupts the assembly of the inflammasome. Apigenin also prevented the formation of a pore-forming protein called gasdermin-D, which immune cells use to release inflammatory signals. Interestingly, this anti-inflammatory action is independent of apigenin’s CD38 inhibition, meaning these are two separate biological effects happening through distinct mechanisms.
Effects on Testosterone Production
In mouse Leydig cells (the cells in the testes responsible for making testosterone), apigenin increased the expression of a protein called StAR, which controls the rate-limiting step in steroid hormone production. StAR acts as a gatekeeper, shuttling cholesterol into the part of the cell where it gets converted into testosterone and other steroid hormones. Apigenin enhanced StAR gene expression at the level of transcription, meaning it increased how much of this gatekeeper protein the cell produced.
The pathway works like this: apigenin blocks a receptor involved in a signaling chain that normally suppresses StAR production. With that suppression removed, even very low levels of the cell’s normal hormonal signaling were enough to trigger maximum StAR protein expression and steroid hormone output. The cells became dramatically more sensitive to their existing hormonal signals. This research was conducted in isolated mouse cells, so the translation to whole-body testosterone levels in humans remains uncertain.
Cancer Cell Research
In laboratory studies on neuroblastoma cells, apigenin activated p53, a tumor-suppressing protein sometimes called the “guardian of the genome.” Within four hours of treatment, p53 levels rose sharply and the protein relocated into the cell nucleus where it could influence gene activity. This triggered a chain of events: levels of a pro-death protein called Bax increased 3.5-fold over 16 hours, enzymes that dismantle cells (caspases) became active, and the cells underwent programmed death.
Critically, apigenin only killed cancer cells that had functional p53. Cells with a mutated, non-functional version of p53 were unaffected, confirming that the effect depends on this specific pathway. When researchers forced cells to overproduce a survival protein called Bcl-XL, it rescued them from apigenin-induced death, further confirming the mechanism. These findings are from cell culture studies and represent a potential mechanism rather than a proven cancer treatment.
Food Sources and Absorption
Dried parsley is by far the richest dietary source of apigenin, containing roughly 45 milligrams per gram. Dried chamomile flowers contain 3 to 5 milligrams per gram. Celery seeds provide about 0.8 milligrams per gram. Fresh versions of these foods contain substantially less because water dilutes the concentration.
When you take apigenin orally, its bioavailability is around 30%, meaning roughly a third of what you swallow reaches your bloodstream. It hits peak blood concentration within 30 minutes to 2.5 hours, and its elimination half-life averages about 2.5 hours. That relatively short half-life means blood levels drop fairly quickly, which is one reason chamomile tea (a traditional source) is often consumed multiple times daily.
Dosage in Human Studies
Most human research has used chamomile extract standardized to apigenin content rather than pure isolated apigenin. For anxiety, one randomized clinical trial used 500 milligrams of chamomile extract three times daily in people with generalized anxiety disorder. For sleep, a separate trial used chamomile flower extract containing at least 2.5 milligrams of apigenin per dose. These are very different amounts of actual apigenin, which makes comparing studies difficult. Standalone apigenin supplements typically range from 50 to 100 milligrams per capsule, though human clinical data on isolated apigenin at these doses is limited.
Drug Interactions and Safety
Apigenin inhibits certain enzymes in the cytochrome P450 family, which your liver uses to metabolize many medications. It inhibits one specific enzyme (CYP4F2) at low concentrations, and broader CYP-mediated drug metabolism can be affected at similar levels. If you take prescription medications, particularly blood thinners or drugs with narrow therapeutic windows, this interaction potential is worth knowing about. The same enzyme system that makes apigenin bioactive also means it can alter how quickly your body processes other compounds.